Where are you in the FDA Process?

Phase I, II and III for NDA or Clinical Studies in Support of PMA

Clinical Tests create a variety of significant liabilities that need addressing:

•   Standard general liability or professional liability policies are not adequate.

•   Human clinical trial liability coverage must be designed so that it does not exclude                   

• expected or intended occurrences

• bodily injury to participants

• Professional liability may be needed for human trial consultants

• World Wide Activities are increasingly common:

    Make sure your carrier can provide "admitted" coverage in countries that require it.